Correction: Dual-responsive nanoparticles targeting ACE-II senescence for therapeutic mitigation of acute lung injury. [PDF]
Gao L, Zheng F, Fu Z, Wang W.
europepmc +1 more source
Ace Alagna was a photographer, editor and publisher of the Italian Tribune, and prominent member of the Italian American community in Newark, NJ. The Ace Alagna photographs consist of photographic negatives, prints, videos, and layout sheets from Ace ...
Alagna, 1925-2000, Ace (Armando)
core
Ace Alagna in military uniform
Ace Alagna was a photographer, editor and publisher of the Italian Tribune, and prominent member of the Italian American community in Newark, NJ. The Ace Alagna photographs consist of photographic negatives, prints, videos, and layout sheets from Ace ...
Alagna, 1925-2000, Ace (Armando)
core
Targeting the ACE/Ang II Axis with Captopril Attenuates Neuroinflammation and Cerebral Injury Following Fat Embolism. [PDF]
Chen SC +12 more
europepmc +1 more source
Angiotensin Converting Enzyme Polymorphism in Prior Anaphylactoid Reaction to Lipoprotein Apheresis. [PDF]
Dal Pino B, Sbrana F.
europepmc +1 more source
Association of ACE I/D polymorphism with blood pressure response to valsartan-hydrochlorothiazide combination therapy in hypertensive patients from Khyber Pakhtunkhwa, Pakistan. [PDF]
Ullah A +5 more
europepmc +1 more source
Angiotensin-Converting Enzyme (ACE) Insertion/Deletion (I/D) Polymorphism and Migraine Susceptibility and Phenotypes: A Clinical-Genetic Study in a United Arab Emirates (UAE) Cohort. [PDF]
ElNebrisi E +7 more
europepmc +1 more source
Individual and Combined Cardioprotective Effects of 1,25(OH)<sub>2</sub>D<sub>3</sub> and Dimethyl Fumarate in an Isoproterenol-Induced Myocardial Injury Model. [PDF]
Karpuzoğlu FH +9 more
europepmc +1 more source
Impact of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers on cardiovascular and non-cardiovascular outcomes in patients at high/very-high cardiovascular risk without heart failure: a systematic review and meta-analysis of randomized, double-blind, placebo-controlled trials <sup>†</sup>. [PDF]
Masi S +3 more
europepmc +1 more source

